Overcoming Obstacles in Gene Therapy Manufacturing

News
Article

Sponsored Content

When it comes to viral vectors, the complexities related to varying serotypes and different sized payloads continue to impact efficiencies and timelines. Hear from Resilience experts on how innovative platform technologies can overcome these challenges and support scalable manufacturing.

Related Content
© 2024 MJH Life Sciences

All rights reserved.